These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36008666)

  • 1. Methods Related to the Immunopathogenesis of Vulvovaginal Candidiasis and Associated Neutrophil Anergy.
    Yano J; Fidel PL
    Methods Mol Biol; 2022; 2542():193-218. PubMed ID: 36008666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Mechanism behind the Immunopathogenesis of Vulvovaginal Candidiasis: "Neutrophil Anergy".
    Yano J; Peters BM; Noverr MC; Fidel PL
    Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29203543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal Heparan Sulfate Linked to Neutrophil Dysfunction in the Acute Inflammatory Response Associated with Experimental Vulvovaginal Candidiasis.
    Yano J; Noverr MC; Fidel PL
    mBio; 2017 Mar; 8(2):. PubMed ID: 28292981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic analysis of vulvovaginal candidiasis identifies a role for the NLRP3 inflammasome.
    Bruno VM; Shetty AC; Yano J; Fidel PL; Noverr MC; Peters BM
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Mechanism of IL-17 Regulating Neutrophils Participating in Host Immunity of RVVC Mice.
    Shao M; Hou M; Li S; Qi W
    Reprod Sci; 2023 Dec; 30(12):3610-3622. PubMed ID: 37438557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
    Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
    Front Immunol; 2022; 13():959740. PubMed ID: 35967437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
    Shao MK; Qi WJ; Hou MY; Luo DD
    J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of the Capacity of the
    Willems HME; Lowes DJ; Barker KS; Palmer GE; Peters BM
    Infect Immun; 2018 Dec; 86(12):. PubMed ID: 30249743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
    Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
    Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbicidal activity of neutrophils is inhibited by isolates from recurrent vaginal candidiasis (RVVC) caused by Candida albicans through fungal thioredoxin reductase.
    Ratti BA; Godoy JS; de Souza Bonfim Mendonça P; Bidóia DL; Nakamura TU; Nakamura CV; Lopes Consolaro ME; Estivalet Svidzinski TI; de Oliveira Silva S
    Cell Immunol; 2015 Jan; 293(1):22-9. PubMed ID: 25497972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
    Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
    Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of butyl alcohol extract of Baitouweng Decoction on vaginal mucosal neutrophil chemotaxis in vulvovaginal candidiasis mice].
    Jiang JJ; Yun Y; Zhang MX; Yang Y; Duan QJ; Wang TM; Shao J; Wang CZ
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(2):361-366. PubMed ID: 32237319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.
    Kan S; Song N; Pang Q; Mei H; Zheng H; Li D; Cui F; Lv G; An R; Li P; Xiong Z; Fan S; Zhang M; Chen Y; Qiao Q; Liang X; Cui M; Li D; Liao Q; Li X; Liu W
    Mycopathologia; 2023 Apr; 188(1-2):99-109. PubMed ID: 36378354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
    Li X; Chen S; Lyu X; Tian J
    Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis.
    Chen Z; Jin J; Chen H; Chen Y; Feng S
    Microb Pathog; 2023 Apr; 177():106037. PubMed ID: 36842517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interleukin (IL) 17R/IL-22R Signaling Axis Is Dispensable for Vulvovaginal Candidiasis Regardless of Estrogen Status.
    Peters BM; Coleman BM; Willems HME; Barker KS; Aggor FEY; Cipolla E; Verma AH; Bishu S; Huppler AH; Bruno VM; Gaffen SL
    J Infect Dis; 2020 Apr; 221(9):1554-1563. PubMed ID: 31805183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autovaccines - potent tool against chronic vulvovaginal candidiasis.
    Koren J; Zaborska M; Varga I; Zahumensky J; Liptakova A
    Bratisl Lek Listy; 2023; 124(6):417-420. PubMed ID: 36876375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.
    MacAlpine J; Lionakis MS
    Cell Host Microbe; 2024 Oct; 32(10):1654-1667. PubMed ID: 39389030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent vulvovaginal candidiasis.
    Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
    Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.